Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 14, 2018
Reporting Period: The filing announces financial results for the quarter and full year ended December 31, 2017.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) containing the actual financial data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release for this information.
Guidance, Outlook, and Risks
The filing references a press release titled "Capricor Presents Fourth Quarter and Full Year 2017 Financial Results and Corporate Update," which likely contains management commentary and outlook. However, the specific text of the 8-K does not detail guidance, risks, contingencies, or unusual items.
Important Facts for Investor Verification
- Verify the specific financial figures (revenue, net loss, cash position) in the attached Exhibit 99.1 press release, as they are not listed in the 8-K body.
- Confirm the company's status as an emerging growth company, as indicated by the checkmark in the filing.
- Note that the information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless expressly stated.